StrokeDx Raises Oversubscribed $5 Million Seed Prime Round to Advance Next-Generation Stroke Technology
May 23 2024 - 10:41AM
Business Wire
StrokeDx, a pioneering stroke technology
company, secures funding to develop and commercialize advanced
technologies for safe cerebrovascular monitoring.
StrokeDx, a pioneer in next-generation stroke technology, today
announced the successful closing of $5 million in Series Seed Prime
funding. The oversubscribed round was led by DigiTx Partners, with
participation by Freeflow Ventures and other existing investors
with extensive accomplishments across neuroradiology, stroke, and
medical devices. David J. Kim, MD, Managing Director of DigiTx
Partners, will be joining the board. To date, StrokeDx’s technology
has raised almost $10 million, including a National Institutes of
Health (NIH) R01 Grant. This latest investment will support further
clinical validation of StrokeDx’s groundbreaking technology and the
expansion of its commercial efforts.
StrokeDx specializes in developing advanced technologies and
software to enable portable, non-invasive, non-radiating
cerebrovascular monitoring. The company’s innovative approach
offers a unique and highly precise method to survey strokes using
next-generation technology developed by Shane Shahrestani, MD, PhD,
at the California Institute of Technology (Caltech).
The societal impact of StrokeDx’s technology is profound,
offering a scalable solution to improve stroke outcomes for
millions of at-risk individuals. By utilizing portable devices,
StrokeDx addresses critical issues in healthcare accessibility and
equity. Stroke remains a leading cause of death and disability
worldwide, and early detection and rapid monitoring are key to
improving survival rates and quality of life.
“Stroke affects millions globally, leading to significant
mortality and long-term disability. This funding enables us to
scale our detection and monitoring solution, empowering physicians
and their patients with an effective tool for point-of-care
cerebrovascular monitoring. Early intervention can significantly
reduce the impact of stroke, shifting the focus from treatment to
prevention,” said Alexander Ballatori, Co-Founder and CEO of
StrokeDx.
“We believe in the potential of StrokeDx’s technology to change
the diagnostic paradigm and ultimately improve outcomes for stroke
patients. By providing accessible, advanced technology, we can
reach millions of at-risk individuals, potentially saving countless
lives and reducing the burden on healthcare systems around the
world,” said David J. Kim, MD, Managing Director of DigiTx
Partners.
About StrokeDx: StrokeDx is at the forefront of
developing next-generation stroke detection technology. Our mission
is to provide early, accurate, and accessible stroke monitoring and
detection solutions to improve patient outcomes and reduce the
global burden of stroke. For more information, visit
www.stroke-dx.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240523058579/en/
Alexander Ballatori, CEO of StrokeDx alex@stroke-dx.com